enliventherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: | ||
Meta Tags
| Title | Enliven Therapeutics | Small Molecule Kinase |
| Description | Advancing Medicine, Restoring We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 192.169.220.85 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
enliventherapeutics.com Valuation
|
US$6,714,212
Last updated: 2023-05-07 14:25:56
enliventherapeutics.com has Semrush global rank of 1,576,403. enliventherapeutics.com has an estimated worth of US$ 6,714,212, based on its estimated Ads revenue. enliventherapeutics.com receives approximately 774,717 unique visitors each day. Its web server is located in United States, with IP address 192.169.220.85. According to SiteAdvisor, enliventherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,714,212 |
| Daily Ads Revenue | US$6,198 |
| Monthly Ads Revenue | US$185,933 |
| Yearly Ads Revenue | US$2,231,185 |
| Daily Unique Visitors | 51,648 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| enliventherapeutics.com. 600 | A | enliventherapeutics.com. 600 | IP: 192.169.220.85 |
| enliventherapeutics.com. 3600 | NS | enliventherapeutics.com. 3600 | NS Record: ns07.domaincontrol.com. |
| enliventherapeutics.com. 3600 | NS | enliventherapeutics.com. 3600 | NS Record: ns08.domaincontrol.com. |
| enliventherapeutics.com. 3600 | MX | enliventherapeutics.com. 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| enliventherapeutics.com. 3600 | MX | enliventherapeutics.com. 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| enliventherapeutics.com. 3600 | MX | enliventherapeutics.com. 3600 | MX Record: 1 aspmx.l.google.com. |
| enliventherapeutics.com. 3600 | MX | enliventherapeutics.com. 3600 | MX Record: 10 aspmx2.googlemail.com. |
| enliventherapeutics.com. 3600 | MX | enliventherapeutics.com. 3600 | MX Record: 10 aspmx3.googlemail.com. |
| enliventherapeutics.com. 3600 | TXT | enliventherapeutics.com. 3600 | TXT Record: docusign=fc09bb5d-b1d5-4ad3-8248-8dd497dbe592 |
| enliventherapeutics.com. 3600 | TXT | enliventherapeutics.com. 3600 | TXT Record: v=verifydomain MS=5744892 |
| enliventherapeutics.com. 3600 | TXT | enliventherapeutics.com. 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
HtmlToTextCheckTime:2023-05-07 14:25:56
| About Us Team Board of Directors Scientific Advisors Approach Pipeline BCR-ABL Program HER2 Program Additional Programs Program Presentations & Publications Investors News Press Releases Presentations Events Stock Information Stock Quote and Chart Historical Price Analyst Coverage Corporate Governance Governance Documents Management Team Board of Directors Scientific Advisors Financials & Filings SEC Filings IR Resources FAQs Email Alerts Contact Us Careers Values Job Opportunities Contact Advancing Medicine, Restoring Lives Learn More Our Mission, Our Passion To help people with cancer to not only live longer, but live better Recognized Explorers, Remarkable Experience We have assembled a team of seasoned drug hunters with significant expertise in discovery and development of small molecule kinase inhibitors to take our programs to greater levels. Our Team Novel Insights, Precision Therapeutics We are developing kinase inhibitors that enhance efficacy through better selectivity and |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 0 Content-Length: 0 Content-Security-Policy: upgrade-insecure-requests Content-Type: text/html; charset=UTF-8 Date: Thu, 28 Oct 2021 05:08:21 GMT Location: https://www.enliventherapeutics.com/ Strict-Transport-Security: max-age=300 Vary: User-Agent X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect X-Content-Type-Options: nosniff X-Redirect-By: WordPress X-Xss-Protection: 1; mode=block HTTP/2 200 server: openresty date: Thu, 28 Oct 2021 05:08:22 GMT content-type: text/html; charset=UTF-8 content-length: 149913 accept-ranges: bytes age: 26119 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
enliventherapeutics.com Whois Information
Domain Name: ENLIVENTHERAPEUTICS.COM Registry Domain ID: 2405935944_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-06-24T22:44:00Z Creation Date: 2019-06-24T22:43:58Z Registry Expiry Date: 2024-06-24T22:43:58Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T22:49:30Z <<< |